Skip to main content
. 2020 Aug 27;8(2):e001141. doi: 10.1136/jitc-2020-001141

Figure 2.

Figure 2

The partial rank correlation coefficient, PRCC, for individual parameters. (A) Atezolizumab monotherapy. (B) Combination therapy. APC, antigen-presenting cell; PD1, programmed cell death protein 1; PD-L1, PD-ligand 1; PRCC, Partial rank correlation coefficient; TCE, T cell engager.